Researchers have used CRISPR gene-editing technology to reduce the characteristic bitterness in grapefruit, according to a report published at refractor.io/biology/crispr-gene-edit-grapefruit-less-bitter/. The bitterness in grapefruit is primarily caused by naturally occurring compounds called naringin and limonin, which some consumers find unpalatable. By targeting the genes responsible for producing these bitter compounds, scientists were able to edit the grapefruit's genetic profile to lower their concentration. CRISPR-Cas9, the widely used gene-editing tool, allows researchers to make precise modifications to DNA sequences without introducing foreign genetic material, a distinction that may carry regulatory implications compared to traditional GMO methods. The development could have significant commercial implications for the citrus industry, potentially making grapefruit more appealing to a broader consumer base and reducing the need for added sugars or processing to mask bitterness. However, it is important to note that the source article is a summary-level report, and the underlying peer-review status of the primary research, the specific institution or research team involved, the sample size of edited plants tested, and the full scope of safety and taste evaluations could not be independently verified from the available source. Consumers and industry stakeholders should await further peer-reviewed publication and regulatory review before drawing conclusions about commercial availability. Source: https://refractor.io/biology/crispr-gene-edit-grapefruit-less-bitter/